Prostate cancer in Asia:A collaborative report  

作　　者：Rui Chen Shancheng Ren 无 Ming Kwong Yiu Ng Chi Fai Wai Sam Cheng Lap Hong Ian Seiji Naito Tadashi Matsuda Elijah Kehinde Ali Kural Jason Yichun Chiu Rainy Umbas Qiang Wei Xiaolei Shi Liqun Zhou Jian Huang Yiran Huang Liping Xie Lulin Ma Changjun Yin Danfeng Xu Kexin Xu Zhangqun Ye Chunxiao Liu Dingwei Ye Xin Gao Qiang Fu Jianquan Hou Jianlin Yuan Dalin He Tiejun Pan Qiang Ding Fengshuo Jin Benkang Shi Gongxian Wang Xiuheng Liu Dongwen Wang Zhoujun Shen Xiangbo Kong Wanhai Xu Yaoliang Deng Haibo Xia Alexa NCohen Xu Gao Chuanliang Xu Yinghao Sun 

机构地区：[1]Department of Urology,Shanghai Changhai Hospital,Second Military Medical University,Shanghai,China [2]Chinese Prostate Cancer Consortium [3]Division of Urology,Department of Surgery,University of Hong Kong,Queen Mary Hospital,Hong Kong,China [4]Division of Urology,Department of Surgery,The Chinese University of Hong Kong,Hong Kong,China [5]Urology Centre,Singapore General Hospital,Singapore [6]Department of Urology,Centro Hospitalar Conde de Sao Januario(CHCSJ)Hospital,Macao,China [7]Department of Urology,Graduate School of Medical Sciences,Kyushu University,Fukuoka,Japan [8]Department of Urology and Andrology,Hirakata Hospital,Kansai Medical University,Osaka,Japan [9]Department of Surgery,Kuwait University,Kuwait [10]Department of Urology,Istanbul Acibadem University,Istanbul,Turkey [11]Department of Urology,Taipei City Hospital,National Yang-Ming University,Taipei,Taiwan,China [12]Division of Urology,Department of Surgery,Faculty of Medicine,University of Indonesia,Jakarta,Indonesia [13]Department of Urology,West China Hospital,Sichuan University,Chengdu,China [14]Department of Urology,Peking University First Hospital,Institute of Urology,Peking University,National Urological Cancer Center,Beijing,China [15]Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou,China [16]Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai,China [17]Department of Urology,First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,China [18]Department of Urology,Peking University Third Hospital,Beijing,China [19]State Key Laboratory of Reproductive Medicine,Department of Urology,The First Affiliated Hospital of Nanjing Medical University,Nanjing,China [20]Department of Urology,Shanghai Changzheng Hospital,Second Military Medical University,Shanghai,China [21]Peking University People’s Hospital,Beijing,China [22]Department of Urology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China [23]Department of Urology,Zhujiang

出　　处：《Asian Journal of Urology》2014年第1期15-29,共15页亚洲泌尿外科杂志（英文）

基　　金：supported by the Program for Changjiang Scholars and Innovative Research Team in University scheme of the Ministry of Education of China(NO.IRT1111);the National Basic Research Program of China(2012CB518300);the National Natural Science Foundation of China(81101946);the Shanghai Pujiang Program(12PJD008);Prostate Cancer Foundation Young Investigator Award,Shanghai Municipal Health and Family Planning Commission Outstanding Young Investigator(XYQ2013077).

摘　　要：The incidence of prostate cancer(PCa)within Asian population used to be much lower than in the Western population;however,in recent years the incidence and mortality rate of PCa in some Asian countries have grown rapidly.This collaborative report summarized the latest epidemiology information,risk factors,and racial differences in PCa diagnosis,current status and new trends in surgery management and novel agents for castration-resistant prostate cancer.We believe such information would be helpful in clinical decision making for urologists and oncologists,health-care ministries and medical researchers.

关 键 词：Prostate cancer Asian population EPIDEMIOLOGY Risk factors Racial differences Surgery management 

分 类 号：R73[医药卫生—肿瘤]